腹腔热灌注化疗在进展期或晚期胃癌的临床应用进展
Advances in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy in Advanced or Advanced Gastric Cancer
DOI: 10.12677/ACM.2022.126777, PDF,   
作者: 杨小茜：青海大学研究生院，青海 西宁；赵君慧*：青海大学附属医院肿瘤内科，青海 西宁
关键词: 胃癌；晚期；腹腔热灌注化疗；Gastric Cancer； Advanced； Hyperthermic Intraperitoneal Chemotherapy
摘要: 胃癌是世界上最常见的癌症之一，与全身治疗相比，腹腔热灌注化疗具有直接向腹腔输送高浓度药物的理论优势，且可减少化疗药物的不良反应。目前多数此类患者受益于腹腔热灌注化疗，尽管总体效果良好，但仍具有广泛争议。本文结合国内外的研究成果，对此类患者行腹腔热灌注化疗的临床应用进行了综述。
Abstract: Gastric cancer is one of the most common cancers in the world. Compared with systemic therapy, hyperthermic intraperitoneal chemotherapy has the theoretical advantage of delivering high con-centration of drugs directly to the abdominal cavity, and can reduce the adverse reactions of chem-otherapy drugs. At present, most of these patients benefit from hyperthermic intraperitoneal chemotherapy, which is still widely controversial despite its good overall effect. This article reviews the clinical application of hyperthermic intraperitoneal chemotherapy in these patients.
文章引用：杨小茜, 赵君慧. 腹腔热灌注化疗在进展期或晚期胃癌的临床应用进展[J]. 临床医学进展, 2022, 12(6): 5364-5369. https://doi.org/10.12677/ACM.2022.126777

参考文献

[1] Globocan Observatory W (2019) Cancer Today—World. International Agency for Research on Cancer, 876, 2018-2019.
[2] Thomassen, I., van Gestel, Y.R., van Ramshorst, B., et al. (2014) Peritoneal Carcinomatosis of Gastric Origin: A Population-Based Study on Incidence, Survival and Risk Factors. International Journal of Cancer, 134, 622-628. [Google Scholar] [CrossRef] [PubMed]
[3] Ikoma, N., Blum, M., Chiang, Y.J., et al. (2016) Yield of Staging Laparos-copy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. Annals of Surgical Oncology, 23, 4332-4337. [Google Scholar] [CrossRef] [PubMed]
[4] Allen, C.J., Newhook, T., Vreeland, T.J., et al. (2019) Yield of Peritoneal Cytology in Staging Patients with Gastric and Gastroesophageal Cancer. Journal of Surgical Oncology, 120, 1350-1357. [Google Scholar] [CrossRef] [PubMed]
[5] Sugarbaker, P.H. (2016) Cytoreductive Surgery and Hyper-thermic Intraperitoneal Chemotherapy in the Management of Gastrointestinal Cancers with Peritoneal Metastases: Pro-gress toward a New Standard of Care. Cancer Treatment Reviews, 48, 42-49. [Google Scholar] [CrossRef] [PubMed]
[6] Yonemura, Y., Canbay, E., Li, Y., et al. (2016) A Comprehensive Treatment for Peritoneal Metastases from Gastric Cancer with Curative Intent. European Journal of Surgical Oncology, 42, 1123-1131. [Google Scholar] [CrossRef] [PubMed]
[7] Seshadri, R.A. and Glehen, O. (2016) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric cancer. World Journal of Gastroenterology, 22, 1114-1130. [Google Scholar] [CrossRef] [PubMed]
[8] Desiderio, J., Chao, J., Melstrom, L., Warner, S., Tozzi, F., Fong, Y., Parisi, A. and Woo, Y. (2017) The 30-Year Experience—A Meta-Analysis of Randomised and High-Quality Non-Randomised Studies of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer. European Journal of Cancer, 79, 1-14. [Google Scholar] [CrossRef] [PubMed]
[9] Ji, Z.H., Peng, K.W., Yu, Y., Li, X.B., Yonemura, Y., Liu, Y., Sugarbaker, P.H. and Li, Y. (2017) Current Status and Future Prospects of Clinical Trials on CRS+HIPEC for Gastric Cancer Peritoneal Metastases. International Journal of Hyperthermia, 33, 562-570. [Google Scholar] [CrossRef] [PubMed]
[10] Dahdaleh, F.S. and Turaga, K.K. (2018) Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis. Surgical Oncology Clinics of North America, 27, 519-537. [Google Scholar] [CrossRef] [PubMed]
[11] Yonemura, Y., Sako, S., Wakama, S., et al. (2019) History of Peri-toneal Surface Malignancy Treatment in Japan. Indian Journal of Surgical Oncology, 10, 3-11. [Google Scholar] [CrossRef] [PubMed]
[12] Jayne, D. (2007) Molecular Biology of Peritoneal Carcinomato-sis. In: Ceelen, W.P., Ed., Cancer Treatment and Research, Springer, Berlin, 21-31. [Google Scholar] [CrossRef] [PubMed]
[13] Ji, Z.H., Peng, K.W. and Li, Y. (2016) Intraperitoneal Free Cancer Cells in Gastric Cancer: Pathology of Peritoneal Carcinomatosis and Rationale for Intraperitoneal Chemothera-py/Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Translational Gastroenterology and Hepatology, 1, 69. [Google Scholar] [CrossRef] [PubMed]
[14] Ji, Z.H., Zhang, Y. and Li, Y. (2021) Intra-Operative Hyperthermic Intraperitoneal Chemotherapy for Prevention and Treatment of Peritoneal Metastases from Gastric Cancer: A Narrative Review. Journal of Gastrointestinal Oncology, 12, S70-S78. [Google Scholar] [CrossRef] [PubMed]
[15] Merboth, F., Garcia, S., Renesse, V.J., Distler, M., Welsch, T., Weitz, J. and Stange, D.E. (2022) Comparative Analysis of Postopera-tive Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer. Oncology Research and Treatment, 45, 45-53. [Google Scholar] [CrossRef] [PubMed]
[16] Fugazzola, P., Coccolini, F., Montori, G., Ceresoli, M., Baggi, P., Costanzo, A., Tomasoni, M., Gregis, F., Nozza, S. and Ansaloni, L. (2017) Overall and Disease-Free Survival in Pa-tients Treated with CRS+HIPEC with Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Carcinomatosis. Journal of Gastrointestinal Oncology, 8, 572-582. [Google Scholar] [CrossRef] [PubMed]
[17] Rihuete Caro, C., Manzanedo, I., Pereira, F., Carrion-Alvarez, L., Serrano, Á. and Pérez-Viejo, E. (2018) Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemother-apy (HIPEC) in Patients with Gastric Cancer and Peritoneal Carcinomatosis. European Journal of Surgical Oncology, 44, 1805-1810. [Google Scholar] [CrossRef] [PubMed]
[18] Koemans, W.J., van der Kaaij, R.T., Wassenaar, E.C.E., Boerma, D., Boot, H., Sikorska, K., Los, M., Grootscholten, C., Hartemink, K.J., Veenhof, A.A.F.A., Kodach, L., Snaebjornsson, P. and van Sandick, J.W. (2021) Tumor Characteristics and Clinical Outcome of Peritoneal Metastasis of Gastric Origin Treated with a Hyperthermic Intraperitoneal Chemotherapy Procedure in the PERISCOPE I Trial. Journal of Surgical Oncology, 123, 904-910. [Google Scholar] [CrossRef] [PubMed]
[19] Zhu, L., Xu, Z., Wu, Y., Liu, P., Qian, J., Yu, S., Xia, B., Lai, J., Ma, S. and Wu, Z. (2020) Prophylactic Chemotherapeutic Hyperthermic Intraperitoneal Perfusion Reduces Peritoneal Metastasis in Gastric Cancer: A Retrospective Clinical Study. BMC Cancer, 20, Article No. 827. [Google Scholar] [CrossRef] [PubMed]
[20] Boerner, T., Graichen, A., Jeiter, T., Zemann, F., Renner, P., März, L., Soeder, Y., Schlitt, H.J., Piso, P. and Dahlke, M.H. (2016) CRS-HIPEC Prolongs Survival but Is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer. Annals of Surgical Oncology, 23, 3972-3977. [Google Scholar] [CrossRef] [PubMed]
[21] Bălescu, I., Godoroja, D., Gongu, M., Tomulescu, V. and Copăescu, C. (2017) Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer—Technique and Early Outcomes of Our First Cases. Chirurgia (Bucur), 112, 714-725. [Google Scholar] [CrossRef] [PubMed]
[22] Badgwell, B., Blum, M., Das, P., Estrella, J., Wang, X., Ho, L., Fournier, K., Royal, R., Mansfield, P. and Ajani, J. (2017) Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Annals of Surgical Oncology, 24, 3338-3344. [Google Scholar] [CrossRef] [PubMed]
[23] Newhook, T.E., Agnes, A., Blum, M., Estrella, J.S., Das, P., Ho, L., Ajani, J.A., Minsky, B.D., Mansfield, P. and Badgwell, B.D. (2019) Laparoscopic Hyperthermic Intraperitoneal Chemotherapy Is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Annals of Surgical Oncology, 26, 1394-1400. [Google Scholar] [CrossRef] [PubMed]
[24] Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, A.C., Rivoire, M., Baulieux, J., et al. (2000) Peritoneal Carcinomatosis from Non-Gynecologic Malignancies: Results of the EVOCAPE 1 Multicentric Prospective Study. Cancer, 88, 358-363. [Google Scholar] [CrossRef] 
[25] Yang, X.J., Huang, C.Q., Suo, T., Mei, L.J., Yang, G.L., Cheng, F.L., et al. (2011) Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Re-sults of a Phase III Randomized Clinical Trial. Annals of Surgical Oncology, 18, 1575-1581. [Google Scholar] [CrossRef] [PubMed]

为你推荐